Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALC Alcon	$87.21 -0.2%	$87.38	$80.48 ▼ $101.10	$43.08B	0.95	1.23 million shs	1.13 million shs
CAH Cardinal Health	$158.66 -0.6%	$158.68	$94.85 ▼ $168.44	$38.08B	0.68	2.24 million shs	1.32 million shs
MCK McKesson	$711.19 +0.2%	$716.44	$464.42 ▼ $737.89	$88.80B	0.48	919,142 shs	395,779 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALC Alcon	0.00%	-0.13%	+2.23%	-4.44%	-2.93%
CAH Cardinal Health	0.00%	-0.88%	-2.23%	+21.42%	+67.79%
MCK McKesson	0.00%	+0.19%	-1.53%	+3.96%	+22.36%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALC Alcon	2.695 of 5 stars	3.4	3.0	0.8	0.0	1.2	0.8	1.3
CAH Cardinal Health	4.8577 of 5 stars	2.4	4.0	4.2	3.6	3.4	1.7	2.5
MCK McKesson	4.5716 of 5 stars	2.4	3.0	3.3	3.0	2.9	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALC Alcon	2.80	Moderate Buy	$106.13	21.69% Upside
CAH Cardinal Health	2.79	Moderate Buy	$158.07	-0.37% Downside
MCK McKesson	2.86	Moderate Buy	$710.17	-0.14% Downside

Current Analyst Ratings Breakdown

Latest CAH, MCK, and ALC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/16/2025	CAH Cardinal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$181.00 ➝ $190.00
7/16/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$770.00 ➝ $810.00
7/15/2025	ALC Alcon	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$90.00 ➝ $84.00
7/14/2025	ALC Alcon	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$100.00
7/9/2025	MCK McKesson	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$760.00 ➝ $800.00
6/13/2025	CAH Cardinal Health	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$166.00 ➝ $181.00
6/13/2025	CAH Cardinal Health	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$157.00 ➝ $170.00
6/12/2025	CAH Cardinal Health	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$175.00 ➝ $180.00
6/11/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$745.00 ➝ $770.00
6/10/2025	CAH Cardinal Health	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$165.00 ➝ $170.00
6/3/2025	CAH Cardinal Health	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$136.00 ➝ $179.00

(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALC Alcon	$9.91B	4.34	$5.55 per share	15.72	$43.70 per share	2.00
CAH Cardinal Health	$222.29B	0.17	$10.47 per share	15.15	($13.19) per share	-12.03
MCK McKesson	$359.05B	0.25	$38.93 per share	18.27	($13.52) per share	-52.60

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALC Alcon	$1.02B	$2.25	38.76	26.51	2.24	11.28%	6.95%	4.92%	8/19/2025 (Estimated)
CAH Cardinal Health	$852M	$6.41	24.75	17.73	1.58	0.70%	-68.84%	4.21%	8/12/2025 (Estimated)
MCK McKesson	$3.30B	$25.83	27.53	19.41	1.42	0.92%	-201.12%	5.83%	8/6/2025 (Estimated)

Latest CAH, MCK, and ALC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q4 2025	CAH Cardinal Health	$2.03	N/A	N/A	N/A	$60.91 billion	N/A
8/6/2025	Q1 2026	MCK McKesson	$8.33	N/A	N/A	N/A	$95.93 billion	N/A
5/13/2025	Q1 2025	ALC Alcon	$0.77	$0.73	-$0.04	$0.70	$2.52 billion	$2.33 billion
5/8/2025	Q4 2025	MCK McKesson	$9.83	$10.12	+$0.29	$10.01	$94.00 billion	$90.82 billion
5/1/2025	Q3 2025	CAH Cardinal Health	$2.15	$2.35	+$0.20	$2.10	$55.33 billion	$54.88 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALC Alcon	N/A	N/A	N/A	N/A	4 Years
CAH Cardinal Health	$2.04	1.29%	N/A	31.83%	29 Years
MCK McKesson	$2.84	0.40%	N/A	10.99%	17 Years

Latest CAH, MCK, and ALC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2025	CAH Cardinal Health	quarterly	$0.5107	1.35%	7/1/2025	7/1/2025	7/15/2025
5/1/2025	MCK McKesson	quarterly	$0.71	0.4%	6/2/2025	6/2/2025	7/1/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALC Alcon	0.21	2.70	1.66
CAH Cardinal Health	N/A	0.94	0.50
MCK McKesson	N/A	0.90	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALC Alcon	53.86%
CAH Cardinal Health	87.17%
MCK McKesson	85.07%

Insider Ownership

Company	Insider Ownership
ALC Alcon	N/A
CAH Cardinal Health	0.09%
MCK McKesson	0.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALC Alcon	25,599	493.24 million	N/A	Optionable
CAH Cardinal Health	48,900	238.68 million	238.46 million	Optionable
MCK McKesson	45,000	125.11 million	125.01 million	Optionable

CAH, MCK, and ALC Headlines

Recent News About These Companies

Clifford Swan Investment Counsel LLC Sells 491 Shares of McKesson Corporation (NYSE:MCK)

July 21 at 10:07 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Bought by HighPoint Advisor Group LLC

July 21 at 9:56 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Acquired by Los Angeles Capital Management LLC

July 21 at 7:51 AM | marketbeat.com

413 Shares in McKesson Corporation (NYSE:MCK) Acquired by Elyxium Wealth LLC

July 21 at 6:18 AM | marketbeat.com

Private Advisor Group LLC Has $6.92 Million Holdings in McKesson Corporation (NYSE:MCK)

July 21 at 5:52 AM | marketbeat.com

Reviewing McKesson (MCK) & The Competition

July 21 at 3:09 AM | americanbankingnews.com

6,816 Shares in McKesson Corporation (NYSE:MCK) Purchased by Meridian Wealth Advisors LLC

July 20 at 9:13 AM | marketbeat.com

Heritage Investors Management Corp Sells 582 Shares of McKesson Corporation (NYSE:MCK)

July 20 at 8:20 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Purchased by Teachers Retirement System of The State of Kentucky

July 20 at 8:20 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Stock Holdings Decreased by Morningstar Investment Services LLC

July 19 at 9:28 AM | marketbeat.com

Mainstay Capital Management LLC ADV Sells 507 Shares of McKesson Corporation (NYSE:MCK)

July 19 at 9:28 AM | marketbeat.com

6,466 Shares in McKesson Corporation (NYSE:MCK) Acquired by Financial Harvest LLC

July 19 at 9:12 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Stock Holdings Decreased by SBI Securities Co. Ltd.

July 19 at 5:27 AM | marketbeat.com

McKesson's (MCK) "Overweight" Rating Reiterated at Morgan Stanley

July 19 at 3:30 AM | americanbankingnews.com

Is McKesson (MCK) an Overlooked Dividend Stock in the Pharma Sector for 2025?

July 18 at 10:28 PM | insidermonkey.com

Patton Albertson Miller Group LLC Has $9.58 Million Position in McKesson Corporation (NYSE:MCK)

July 18 at 9:10 AM | marketbeat.com

Forte Capital LLC ADV Grows Stock Holdings in McKesson Corporation (NYSE:MCK)

July 18 at 9:01 AM | marketbeat.com

Forum Financial Management LP Has $1.04 Million Holdings in McKesson Corporation (NYSE:MCK)

July 18 at 8:49 AM | marketbeat.com

Critical Analysis: McKesson (MCK) versus Its Competitors

July 18 at 3:53 AM | americanbankingnews.com

Contrasting McKesson (MCK) & The Competition

July 18 at 2:59 AM | americanbankingnews.com

Analysts Set McKesson Corporation (NYSE:MCK) PT at $706.83

July 18 at 2:37 AM | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CAH, MCK, and ALC Company Descriptions

Alcon NYSE:ALC

$87.21 -0.14 (-0.16%)

Closing price 03:58 PM Eastern

Extended Trading

$87.23 +0.02 (+0.03%)

As of 07:32 PM Eastern

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Cardinal Health NYSE:CAH

$158.66 -0.90 (-0.56%)

Closing price 03:58 PM Eastern

Extended Trading

$158.44 -0.23 (-0.14%)

As of 07:29 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

McKesson NYSE:MCK

$711.19 +1.39 (+0.20%)

Closing price 03:58 PM Eastern

Extended Trading

$709.16 -2.03 (-0.29%)

As of 06:29 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time